Literature DB >> 24140057

A rapid screening and production method using a novel mammalian cell display to isolate human monoclonal antibodies.

Kosuke Tomimatsu1, Shin-ei Matsumoto, Hayato Tanaka, Makiko Yamashita, Hidekazu Nakanishi, Kiichiro Teruya, Saiko Kazuno, Tomoya Kinjo, Takeki Hamasaki, Ken-ichi Kusumoto, Shigeru Kabayama, Yoshinori Katakura, Sanetaka Shirahata.   

Abstract

Antibody display methods are increasingly being used to produce human monoclonal antibodies for disease therapy. Rapid screening and isolation of specific human antibody genes are valuable for producing human monoclonal antibodies showing high specificity and affinity. In this report, we describe a novel mammalian cell display method in which whole human IgG is displayed on the cell surface of CHO cells. Cells expressing antigen-specific human monoclonal IgGs with high affinity on the cell surface after normal folding and posttranscriptional modification were screened using a cell sorter. The membrane-type IgG-expressing CHO cells were then converted to IgG-secreting cells by transfection with a plasmid coding Cre recombinase. This mammalian cell display method was applied to in vitro affinity maturation of monoclonal C9 IgG specific to the human high-affinity IgE receptor (FcεRIα). The CDR3 of the C9 heavy chain variable region gene was randomly mutated and inserted into pcDNA5FRT/IgG. A C9 IgG (CDRH3r)-expressing CHO cell display library consisting of 1.1×10(6) independent clones was constructed. IgG-displaying cells showing high reactivity to FcεRIα antigen were screened by the cell sorter, resulting in the establishment of a CHO cell line producing with higher reactivity than the parent C9 IgG.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHO cells; Cre recombinase; Human high affinity IgE receptor; Human monoclonal antibody; In vitro maturation; Mammalian cell display

Mesh:

Substances:

Year:  2013        PMID: 24140057     DOI: 10.1016/j.bbrc.2013.10.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.

Authors:  Jeremiah D Heredia; Jihye Park; Riley J Brubaker; Steven K Szymanski; Kevin S Gill; Erik Procko
Journal:  J Immunol       Date:  2018-04-20       Impact factor: 5.422

2.  Identification of high affinity HER2 binding antibodies using CHO Fab surface display.

Authors:  Annalee W Nguyen; Kevin C Le; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2018-03-01       Impact factor: 1.650

Review 3.  Immune Literacy: Reading, Writing, and Editing Adaptive Immunity.

Authors:  Lucia Csepregi; Roy A Ehling; Bastian Wagner; Sai T Reddy
Journal:  iScience       Date:  2020-09-01

4.  Antibody discovery and engineering by enhanced CRISPR-Cas9 integration of variable gene cassette libraries in mammalian cells.

Authors:  Cristina Parola; Daniel Neumeier; Simon Friedensohn; Lucia Csepregi; Mariangela Di Tacchio; Derek M Mason; Sai T Reddy
Journal:  MAbs       Date:  2019-09-16       Impact factor: 5.857

5.  Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats.

Authors:  Ryutaro Asano; Katsuhiro Hosokawa; Shintaro Taki; Shota Konno; Ippei Shimomura; Hiromi Ogata; Mai Okada; Kyoko Arai; Masayoshi Onitsuka; Takeshi Omasa; Takeshi Nakanishi; Mitsuo Umetsu; Izumi Kumagai
Journal:  Sci Rep       Date:  2020-03-18       Impact factor: 4.379

Review 6.  Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.

Authors:  Zehua Sun; Lixin Yan; Jiansong Tang; Qian Qian; Jerica Lenberg; Dandan Zhu; Wan Liu; Kao Wu; Yilin Wang; Shiqiang Lu
Journal:  Virus Res       Date:  2017-10-16       Impact factor: 3.303

7.  A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms.

Authors:  Yu-Jia Jin; Diao Yu; Xiao-Long Tian; Hui-Xian Li; Xiao-Chao Zhou; Yu Kong; Wei Zhang; Lu Zhang; Cheng Lei; Zhen-Lin Yang; Chao Tu; Yan-Ling Wu; Tian-Lei Ying
Journal:  Acta Pharmacol Sin       Date:  2021-07-07       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.